At the ISCT 2014 meeting in Paris at the end of next month, Akron Biotech CEO Dr. Claudia Zylberberg will co-host a plenary session panel on the past, present and future of cell therapies. In advance of the meeting, the International Society of Cell Therapy interviewed Dr. Zylberberg for their Pre-Event Podcast series, in which Dr. Zylberberg discusses the current regulatory and clinical state of cell therapies, including raw materials quality, in process controls, logistics, business modelsas well as the current regulatory climate including funding.
Listen to the informative podcast here.
For more information and to listen to Dr. Zylberberg speak at ISCT, she will participate in the panel “Ancillary Materials for Cellular Therapies” on Thursday April 24th.
The International Society of Cellular Therapy 20th Annual Meeting takes place in Paris from April 23 – 26, 2014. Register to attend here.